id	sid	eid	entity	type
globalce-157	1	1	5	CARDINAL
globalce-157	1	2	1	CARDINAL
globalce-157	1	3	2023	CARDINAL
globalce-157	1	4	5	CARDINAL
globalce-157	1	5	2023	CARDINAL
globalce-157	1	6	october 3	DATE
globalce-157	1	7	2023	CARDINAL
globalce-157	1	8	november 28	DATE
globalce-157	1	9	2023	CARDINAL
globalce-157	1	10	fda	ORG
globalce-157	1	11	maude	ORG
globalce-157	1	12	spilios zisimopoulos	PERSON
globalce-157	1	13	nicolas pallikarakis institute of biomedical technology	ORG
globalce-157	1	14	greece	GPE
globalce-157	2	1	md	GPE
globalce-157	4	1	maude	ORG
globalce-157	4	2	fda	ORG
globalce-157	4	3	mdrs	PERSON
globalce-157	4	4	fda	ORG
globalce-157	4	5	1991	DATE
globalce-157	5	1	md	GPE
globalce-157	5	2	the last three decades	DATE
globalce-157	6	1	maude	ORG
globalce-157	6	2	1991	DATE
globalce-157	6	3	11/2022	CARDINAL
globalce-157	8	1	md groups	GPE
globalce-157	10	1	annual	DATE
globalce-157	11	1	about 15 million	CARDINAL
globalce-157	11	2	maude	PERSON
globalce-157	11	3	the 30 years	DATE
globalce-157	11	4	more than 2.5 million	MONEY
globalce-157	11	5	the first 10 months	DATE
globalce-157	11	6	2022	CARDINAL
globalce-157	13	1	63.5%	PERCENT
globalce-157	14	1	98.4%	PERCENT
globalce-157	14	2	3.2%	PERCENT
globalce-157	15	1	about 20%	PERCENT
globalce-157	16	1	96%	PERCENT
globalce-157	16	2	over 70%	PERCENT
globalce-157	16	3	fda 21 cfr	ORG
globalce-157	16	4	803	CARDINAL
globalce-157	17	1	5.4 years	DATE
globalce-157	17	2	the years	DATE
globalce-157	17	3	43%	PERCENT
globalce-157	17	4	their first year	DATE
globalce-157	19	1	maude	ORG
globalce-157	19	2	mds	GPE
globalce-157	20	1	fda	ORG
globalce-157	21	1	maude	PERSON
globalce-157	21	2	fda	ORG
globalce-157	22	1	2023	CARDINAL
globalce-157	23	1	4.0	CARDINAL
globalce-157	23	2	4.0	CARDINAL
globalce-157	26	1	fda	ORG
globalce-157	26	2	maude	ORG
globalce-157	26	3	1	CARDINAL
globalce-157	26	4	2023 6	CARDINAL
globalce-157	26	5	today	DATE
globalce-157	30	1	authorities1	PERSON
globalce-157	30	2	md	GPE
globalce-157	31	1	md vigilance systems	ORG
globalce-157	31	2	more than 30 years	DATE
globalce-157	32	1	md	GPE
globalce-157	34	1	md	GPE
globalce-157	36	1	one	CARDINAL
globalce-157	36	2	md	GPE
globalce-157	45	1	maude	ORG
globalce-157	45	2	fda	ORG
globalce-157	45	3	the last three decades	DATE
globalce-157	48	1	fda	ORG
globalce-157	48	2	maude	PERSON
globalce-157	48	3	maude	ORG
globalce-157	48	4	7	CARDINAL
globalce-157	48	5	1	CARDINAL
globalce-157	48	6	2023	CARDINAL
globalce-157	48	7	fda	ORG
globalce-157	48	8	maude	ORG
globalce-157	48	9	mds	GPE
globalce-157	49	1	the european databank	ORG
globalce-157	49	2	the european union	ORG
globalce-157	49	3	eu	ORG
globalce-157	49	4	mds	GPE
globalce-157	50	1	the 2000s	DATE
globalce-157	50	2	90/385	CARDINAL
globalce-157	50	3	93/42	CARDINAL
globalce-157	50	4	md	GPE
globalce-157	50	5	98/79	CARDINAL
globalce-157	50	6	ec	ORG
globalce-157	51	1	eu	ORG
globalce-157	51	2	2.12/1	CARDINAL
globalce-157	51	3	2012(b	CARDINAL
globalce-157	51	4	2019.(c	PRODUCT
globalce-157	51	5	eu	ORG
globalce-157	51	6	2017/745	CARDINAL
globalce-157	51	7	2017/746	ORG
globalce-157	53	1	australian	NORP
globalce-157	53	2	tga	ORG
globalce-157	53	3	canada	GPE
globalce-157	53	4	uk	GPE
globalce-157	53	5	germany	GPE
globalce-157	53	6	federal institute for drugs and medical devices	ORG
globalce-157	55	1	2000	DATE
globalce-157	55	2	maude	PERSON
globalce-157	55	3	maude	ORG
globalce-157	56	1	maude	ORG
globalce-157	56	2	303	CARDINAL
globalce-157	57	1	fda	ORG
globalce-157	57	2	maude	ORG
globalce-157	58	1	fda	ORG
globalce-157	60	1	maude	ORG
globalce-157	61	1	308	CARDINAL
globalce-157	61	2	2022	CARDINAL
globalce-157	61	3	1	CARDINAL
globalce-157	61	4	31	CARDINAL
globalce-157	61	5	the first quarter	DATE
globalce-157	61	6	2023	CARDINAL
globalce-157	62	1	recent years	DATE
globalce-157	62	2	catheters.10–14	ORG
globalce-157	62	3	the last years	DATE
globalce-157	62	4	maude	ORG
globalce-157	63	1	groups.15–17	ORG
globalce-157	63	2	maude	ORG
globalce-157	63	3	2019	DATE
globalce-157	63	4	2	CARDINAL
globalce-157	64	1	maude	ORG
globalce-157	64	2	the last ten years	DATE
globalce-157	64	3	ttps://ec.europa.eu/docsroom/documents/32305	NORP
globalce-157	64	4	1	CARDINAL
globalce-157	64	5	maude	PERSON
globalce-157	65	1	ttps://ec.europa.eu/docsroom/documents/32305	NORP
globalce-157	65	2	fda	ORG
globalce-157	65	3	maude	ORG
globalce-157	66	1	1	CARDINAL
globalce-157	66	2	2023 8	DATE
globalce-157	66	3	mds	PERSON
globalce-157	67	1	malataras	ORG
globalce-157	67	2	n. pallikarakis	PERSON
globalce-157	67	3	maude	PERSON
globalce-157	67	4	between the years 2005	DATE
globalce-157	67	5	2014,9	CARDINAL
globalce-157	67	6	each year	DATE
globalce-157	68	1	the last couple of years	DATE
globalce-157	68	2	fda	ORG
globalce-157	68	3	maude	ORG
globalce-157	68	4	2	CARDINAL
globalce-157	69	1	maude	PERSON
globalce-157	70	1	maude	PERSON
globalce-157	70	2	1991	DATE
globalce-157	73	1	fda	ORG
globalce-157	73	2	maude	ORG
globalce-157	73	3	maude	PERSON
globalce-157	73	4	1991	DATE
globalce-157	73	5	2022	CARDINAL
globalce-157	73	6	1991	DATE
globalce-157	73	7	1993	DATE
globalce-157	73	8	1996	DATE
globalce-157	74	1	the year 1997	DATE
globalce-157	74	2	between 1991 up to 1997	DATE
globalce-157	74	3	maude	ORG
globalce-157	74	4	foidevthru1997	FAC
globalce-157	75	1	2022	CARDINAL
globalce-157	75	2	maude	PERSON
globalce-157	75	3	4/11/2022	DATE
globalce-157	76	1	the year 2022	DATE
globalce-157	77	1	the year	DATE
globalce-157	78	1	2021	CARDINAL
globalce-157	78	2	the present year (i.e.	DATE
globalce-157	78	3	2022	CARDINAL
globalce-157	79	1	mdr_report_key	ORG
globalce-157	80	1	mdrfoi	GPE
globalce-157	81	1	15,387,348	CARDINAL
globalce-157	82	1	15,386,069	CARDINAL
globalce-157	83	1	15,343,314	CARDINAL
globalce-157	84	1	maude	PERSON
globalce-157	85	1	each year	DATE
globalce-157	85	2	2022	CARDINAL
globalce-157	86	1	age (year	DATE
globalce-157	86	2	minus year	DATE
globalce-157	87	1	3500a	DATE
globalce-157	88	1	fda	ORG
globalce-157	88	2	2	CARDINAL
globalce-157	88	3	annual	DATE
globalce-157	89	1	4/11/2022 9	DATE
globalce-157	89	2	1	CARDINAL
globalce-157	89	3	2023	CARDINAL
globalce-157	89	4	fda	ORG
globalce-157	89	5	maude database	PERSON
globalce-157	91	1	only one	CARDINAL
globalce-157	95	1	h7	PRODUCT
globalce-157	95	2	3500a	DATE
globalce-157	96	1	maude	PERSON
globalce-157	96	2	nan	GPE
globalce-157	97	1	21	CARDINAL
globalce-157	97	2	7	CARDINAL
globalce-157	97	3	fda	ORG
globalce-157	97	4	fda	ORG
globalce-157	99	1	fda	ORG
globalce-157	100	1	fda	ORG
globalce-157	103	1	one	CARDINAL
globalce-157	103	2	fda	ORG
globalce-157	106	1	3500	CARDINAL
globalce-157	106	2	3500a	DATE
globalce-157	109	1	fda	ORG
globalce-157	109	2	3500a	DATE
globalce-157	110	1	three	CARDINAL
globalce-157	110	2	maude	PERSON
globalce-157	111	1	cfr 21	ORG
globalce-157	111	2	803	CARDINAL
globalce-157	113	1	3500a	DATE
globalce-157	116	1	fda	ORG
globalce-157	116	2	maude	ORG
globalce-157	116	3	1	CARDINAL
globalce-157	116	4	2023 10	DATE
globalce-157	116	5	the year	DATE
globalce-157	116	6	3500a	DATE
globalce-157	116	7	the year	DATE
globalce-157	116	8	fda	ORG
globalce-157	119	1	md	GPE
globalce-157	119	2	each year	DATE
globalce-157	119	3	1	CARDINAL
globalce-157	119	4	fda	ORG
globalce-157	119	5	1997	DATE
globalce-157	119	6	2022	CARDINAL
globalce-157	119	7	1	CARDINAL
globalce-157	119	8	about 15 million	CARDINAL
globalce-157	119	9	maude	PERSON
globalce-157	119	10	2022	CARDINAL
globalce-157	119	11	2.5 million	CARDINAL
globalce-157	119	12	the last year	DATE
globalce-157	120	1	the last few years	DATE
globalce-157	121	1	2	CARDINAL
globalce-157	121	2	6	CARDINAL
globalce-157	121	3	md groups	GPE
globalce-157	121	4	fda	ORG
globalce-157	121	5	maude	PERSON
globalce-157	122	1	2	CARDINAL
globalce-157	122	2	63.5%	PERCENT
globalce-157	123	1	about 1%	PERCENT
globalce-157	124	1	2	CARDINAL
globalce-157	124	2	md groups	GPE
globalce-157	125	1	89.1 10.7 0.2 ≈ 0.0	QUANTITY
globalce-157	125	2	90.2 9.0 ≈ 0.0 0.8	QUANTITY
globalce-157	125	3	98.3	CARDINAL
globalce-157	127	1	non-crt	PERSON
globalce-157	127	2	36.3 60.0 3.2 ≈ 0.5	QUANTITY
globalce-157	127	3	2.7	CARDINAL
globalce-157	127	4	0.3 ≈ 0.0	QUANTITY
globalce-157	127	5	1.6 98.4	QUANTITY
globalce-157	128	1	0.0 ≈ 0.0	QUANTITY
globalce-157	128	2	63.5	CARDINAL
globalce-157	128	3	34.3 1.2 1.0	QUANTITY
globalce-157	129	1	3	CARDINAL
globalce-157	129	2	2.5%	PERCENT
globalce-157	129	3	1997	DATE
globalce-157	129	4	0.3%	PERCENT
globalce-157	129	5	2022	CARDINAL
globalce-157	129	6	0.66	CARDINAL
globalce-157	130	1	7.5%	PERCENT
globalce-157	130	2	1997	DATE
globalce-157	130	3	almost 0%	PERCENT
globalce-157	130	4	2022	CARDINAL
globalce-157	130	5	0.85	CARDINAL
globalce-157	130	6	1	CARDINAL
globalce-157	130	7	fda	ORG
globalce-157	130	8	cfr hexokinase	PERSON
globalce-157	130	9	lws	ORG
globalce-157	130	10	non-crt	PERSON
globalce-157	130	11	11	CARDINAL
globalce-157	130	12	1	CARDINAL
globalce-157	130	13	2023	CARDINAL
globalce-157	130	14	fda	ORG
globalce-157	130	15	maude	PERSON
globalce-157	130	16	fda	ORG
globalce-157	130	17	the years	DATE
globalce-157	131	1	73%	PERCENT
globalce-157	131	2	2022	CARDINAL
globalce-157	131	3	only 40%	PERCENT
globalce-157	131	4	1997	DATE
globalce-157	131	5	38%	PERCENT
globalce-157	132	1	49.2%	PERCENT
globalce-157	132	2	the period 1991 1997	DATE
globalce-157	132	3	26.6%	PERCENT
globalce-157	132	4	2022	CARDINAL
globalce-157	133	1	2	CARDINAL
globalce-157	133	2	more than 90%	PERCENT
globalce-157	133	3	about 10%	PERCENT
globalce-157	134	1	about 95%	PERCENT
globalce-157	135	1	98.4%	PERCENT
globalce-157	136	1	3.2%	PERCENT
globalce-157	137	1	over 98%	PERCENT
globalce-157	138	1	4	CARDINAL
globalce-157	138	2	80%	PERCENT
globalce-157	139	1	the remaining	PERCENT
globalce-157	139	2	20%	PERCENT
globalce-157	139	3	three-quarters	CARDINAL
globalce-157	139	4	3	CARDINAL
globalce-157	140	1	2011	DATE
globalce-157	140	2	2013	DATE
globalce-157	140	3	2014	DATE
globalce-157	141	1	the mid ‘10s	DATE
globalce-157	141	2	the older years	DATE
globalce-157	142	1	7%	PERCENT
globalce-157	143	1	3	CARDINAL
globalce-157	144	1	9	CARDINAL
globalce-157	144	2	10	CARDINAL
globalce-157	145	1	69.7%	PERCENT
globalce-157	145	2	26.0%	PERCENT
globalce-157	146	1	about 1	CARDINAL
globalce-157	146	2	10	CARDINAL
globalce-157	147	1	38.0%	PERCENT
globalce-157	147	2	28.6%	PERCENT
globalce-157	147	3	23.3%	PERCENT
globalce-157	148	1	3	CARDINAL
globalce-157	150	1	zisimopoulos	PERSON
globalce-157	150	2	fda	ORG
globalce-157	150	3	maude	ORG
globalce-157	150	4	1	CARDINAL
globalce-157	150	5	2023 12	CARDINAL
globalce-157	150	6	96%	PERCENT
globalce-157	150	7	5	CARDINAL
globalce-157	152	1	the last 4 years	DATE
globalce-157	153	1	these years	DATE
globalce-157	154	1	6	CARDINAL
globalce-157	155	1	fda	ORG
globalce-157	155	2	fda	ORG
globalce-157	157	1	the years 2012 and	DATE
globalce-157	157	2	2013	DATE
globalce-157	158	1	between 2013 and 2018	DATE
globalce-157	158	2	about 15%	PERCENT
globalce-157	158	3	21%	PERCENT
globalce-157	158	4	2016	DATE
globalce-157	160	1	2019	DATE
globalce-157	161	1	4	CARDINAL
globalce-157	164	1	3	CARDINAL
globalce-157	165	1	md groupss	GPE
globalce-157	165	2	93.58 0.01	MONEY
globalce-157	165	3	0.01 ≈ 0.0	QUANTITY
globalce-157	165	4	9.55 0.10	CARDINAL
globalce-157	165	5	0.02	CARDINAL
globalce-157	166	1	0.0 0.40	CARDINAL
globalce-157	166	2	89.86 9.53 0.05	MONEY
globalce-157	167	1	0.0 0.03	CARDINAL
globalce-157	167	2	0.36	CARDINAL
globalce-157	167	3	0.06	CARDINAL
globalce-157	167	4	0.06 0.01	CARDINAL
globalce-157	167	5	74.0	CARDINAL
globalce-157	167	6	0.5 13	CARDINAL
globalce-157	167	7	1	CARDINAL
globalce-157	167	8	2023	CARDINAL
globalce-157	167	9	fda	ORG
globalce-157	167	10	maude	PERSON
globalce-157	167	11	24%	PERCENT
globalce-157	167	12	2021	CARDINAL
globalce-157	167	13	the last 4 years	DATE
globalce-157	168	1	the previous five years	DATE
globalce-157	168	2	2022	CARDINAL
globalce-157	168	3	35%	PERCENT
globalce-157	169	1	7	CARDINAL
globalce-157	170	1	more than half	CARDINAL
globalce-157	170	2	52.3%	PERCENT
globalce-157	170	3	70.8%	PERCENT
globalce-157	171	1	2022	CARDINAL
globalce-157	171	2	55%	PERCENT
globalce-157	172	1	maude	PERSON
globalce-157	172	2	5.4 years	DATE
globalce-157	173	1	the last couple of years	DATE
globalce-157	173	2	8	CARDINAL
globalce-157	173	3	2019	DATE
globalce-157	173	4	2.8 years	DATE
globalce-157	175	1	43%	PERCENT
globalce-157	175	2	their first year	DATE
globalce-157	176	1	5	CARDINAL
globalce-157	177	1	6	CARDINAL
globalce-157	179	1	7	CARDINAL
globalce-157	180	1	fda	ORG
globalce-157	180	2	maude	ORG
globalce-157	181	1	1	CARDINAL
globalce-157	181	2	2023 14	DATE
globalce-157	181	3	the last years	DATE
globalce-157	181	4	1	CARDINAL
globalce-157	182	1	one	CARDINAL
globalce-157	184	1	fda	ORG
globalce-157	184	2	maude	PERSON
globalce-157	185	1	fda	ORG
globalce-157	185	2	3500/ 3500a	DATE
globalce-157	186	1	21	DATE
globalce-157	187	1	2014	DATE
globalce-157	187	2	2015	DATE
globalce-157	188	1	fda	ORG
globalce-157	188	2	30 calendar days	DATE
globalce-157	189	1	5	CARDINAL
globalce-157	190	1	fda	ORG
globalce-157	190	2	10 days	DATE
globalce-157	192	1	2014	DATE
globalce-157	192	2	fda	ORG
globalce-157	192	3	2015	DATE
globalce-157	192	4	mdrs	PERSON
globalce-157	192	5	fda	ORG
globalce-157	192	6	fda	ORG
globalce-157	193	1	the previous two decades	DATE
globalce-157	194	1	21,22	ORDINAL
globalce-157	195	1	maude	PERSON
globalce-157	195	2	2	CARDINAL
globalce-157	195	3	more than 180,000	CARDINAL
globalce-157	196	1	8	CARDINAL
globalce-157	197	1	annual	DATE
globalce-157	200	1	the food and drug administration	ORG
globalce-157	201	1	2014	DATE
globalce-157	202	1	2015	DATE
globalce-157	203	1	15	CARDINAL
globalce-157	203	2	1	CARDINAL
globalce-157	203	3	2023	CARDINAL
globalce-157	203	4	fda	ORG
globalce-157	203	5	maude	ORG
globalce-157	204	1	3	CARDINAL
globalce-157	204	2	the past years	DATE
globalce-157	206	1	2	CARDINAL
globalce-157	209	1	3	CARDINAL
globalce-157	211	1	98.4%	PERCENT
globalce-157	212	1	american	NORP
globalce-157	212	2	fda	ORG
globalce-157	213	1	3.2%	PERCENT
globalce-157	217	1	tubing.23	ORG
globalce-157	220	1	the last year	DATE
globalce-157	222	1	96%	PERCENT
globalce-157	222	2	5	CARDINAL
globalce-157	222	3	cfr 21	ORG
globalce-157	222	4	803	CARDINAL
globalce-157	223	1	7	CARDINAL
globalce-157	224	1	fda	ORG
globalce-157	226	1	1997	DATE
globalce-157	226	2	1991	DATE
globalce-157	226	3	that year	DATE
globalce-157	227	1	maude	ORG
globalce-157	227	2	1991	DATE
globalce-157	227	3	1993	DATE
globalce-157	227	4	1996	DATE
globalce-157	228	1	1996	DATE
globalce-157	228	2	the next years	DATE
globalce-157	229	1	cfr 21	ORG
globalce-157	229	2	803	CARDINAL
globalce-157	231	1	70.8%	PERCENT
globalce-157	232	1	the last year	DATE
globalce-157	233	1	maude	PERSON
globalce-157	234	1	first	ORDINAL
globalce-157	235	1	fda	ORG
globalce-157	235	2	maude	ORG
globalce-157	235	3	1	CARDINAL
globalce-157	235	4	2023 16	CARDINAL
globalce-157	237	1	the current year	DATE
globalce-157	238	1	2023	CARDINAL
globalce-157	238	2	2022	CARDINAL
globalce-157	239	1	5	CARDINAL
globalce-157	241	1	maude	ORG
globalce-157	243	1	the last years	DATE
globalce-157	243	2	fda	ORG
globalce-157	247	1	more than one	CARDINAL
globalce-157	247	2	maude	ORG
globalce-157	251	1	fda	ORG
globalce-157	251	2	maude	PERSON
globalce-157	253	1	europe	LOC
globalce-157	253	2	the md regulations	FAC
globalce-157	254	1	europe	LOC
globalce-157	257	1	1	CARDINAL
globalce-157	258	1	wiig s	PERSON
globalce-157	258	2	aase k	PERSON
globalce-157	260	1	2023	CARDINAL
globalce-157	262	1	fda	ORG
globalce-157	265	1	fda	ORG
globalce-157	265	2	2023	CARDINAL
globalce-157	266	1	2023	CARDINAL
globalce-157	267	1	3	CARDINAL
globalce-157	267	2	fda	ORG
globalce-157	268	1	2023	CARDINAL
globalce-157	269	1	2023	CARDINAL
globalce-157	270	1	4	CARDINAL
globalce-157	271	1	2023	CARDINAL
globalce-157	272	1	5	CARDINAL
globalce-157	273	1	australia department of health	ORG
globalce-157	274	1	tga	ORG
globalce-157	277	1	2022	CARDINAL
globalce-157	278	1	2023	CARDINAL
globalce-157	279	1	https://ec.europa.eu/tools/eudamed/#/screen/home	CARDINAL
globalce-157	279	2	17	CARDINAL
globalce-157	279	3	1	CARDINAL
globalce-157	279	4	2023	CARDINAL
globalce-157	279	5	fda	ORG
globalce-157	279	6	maude	ORG
globalce-157	279	7	6	CARDINAL
globalce-157	280	1	canada health canada	ORG
globalce-157	282	1	2021	CARDINAL
globalce-157	283	1	2023	CARDINAL
globalce-157	284	1	mhra.gov.uk	PERSON
globalce-157	285	1	2023	CARDINAL
globalce-157	286	1	2023	CARDINAL
globalce-157	288	1	8	CARDINAL
globalce-157	288	2	federal institute for drug and medical devices	ORG
globalce-157	290	1	2023	CARDINAL
globalce-157	291	1	https://www.bfarm.de/en/medicaldevices/tasks/risk-assessment-and-research/fieldcorrective-actions/_node.html 9	DATE
globalce-157	292	1	malataras	PERSON
globalce-157	294	1	fda	ORG
globalce-157	294	2	maude	ORG
globalce-157	295	1	global ce j. 2018;1(1):9–23.	PERSON
globalce-157	296	1	10	CARDINAL
globalce-157	297	1	hanba	PERSON
globalce-157	297	2	carron m	ORG
globalce-157	300	1	2018 may 1;20(3):207–14	DATE
globalce-157	301	1	11	CARDINAL
globalce-157	302	1	rahimpour s	PERSON
globalce-157	302	2	kiyani m	PERSON
globalce-157	302	3	hodges se	PERSON
globalce-157	302	4	turner da.	PERSON
globalce-157	304	1	clin neurol neurosurg	PERSON
globalce-157	305	1	2021	CARDINAL
globalce-157	306	1	12	CARDINAL
globalce-157	307	1	carey j	PERSON
globalce-157	308	1	fda	ORG
globalce-157	310	1	2022	CARDINAL
globalce-157	311	1	13	CARDINAL
globalce-157	311	2	tong jy	PERSON
globalce-157	311	3	pasick lj	PERSON
globalce-157	311	4	benito da	PERSON
globalce-157	313	1	otol neurotol	PERSON
globalce-157	314	1	2022	CARDINAL
globalce-157	314	2	feb 1;43(2):e229–34	DATE
globalce-157	315	1	14	CARDINAL
globalce-157	316	1	dayco j	PERSON
globalce-157	316	2	almas t	PERSON
globalce-157	316	3	ahmed ak	PERSON
globalce-157	318	1	maude	PERSON
globalce-157	319	1	ann med surg	PERSON
globalce-157	320	1	2022	CARDINAL
globalce-157	321	1	15	CARDINAL
globalce-157	321	2	cohen kb	PERSON
globalce-157	322	1	fda	ORG
globalce-157	324	1	5(1):12.	CARDINAL
globalce-157	325	1	kavanagh kt	PERSON
globalce-157	325	2	kraman ss	PERSON
globalce-157	325	3	calderon le	ORG
globalce-157	325	4	kavanagh	PERSON
globalce-157	325	5	fda	ORG
globalce-157	325	6	maude	ORG
globalce-157	326	1	patient relat	PERSON
globalce-157	326	2	meas	GPE
globalce-157	327	1	2019	CARDINAL
globalce-157	327	2	17	CARDINAL
globalce-157	328	1	connor mj	PERSON
globalce-157	328	2	tringale k	PERSON
globalce-157	328	3	marshall dc	PERSON
globalce-157	328	4	moore k	PERSON
globalce-157	329	1	u.s.	GPE
globalce-157	329	2	food and drug administration data	ORG
globalce-157	329	3	2002–2015	CARDINAL
globalce-157	331	1	2017	CARDINAL
globalce-157	332	1	18	CARDINAL
globalce-157	335	1	2021	CARDINAL
globalce-157	335	2	jan 6;15(1):2	DATE
globalce-157	336	1	19	CARDINAL
globalce-157	336	2	drugwatch	PERSON
globalce-157	338	1	2023	CARDINAL
globalce-157	339	1	fda	ORG
globalce-157	340	1	20	CARDINAL
globalce-157	341	1	fda	ORG
globalce-157	343	1	2014	DATE
globalce-157	344	1	2023	CARDINAL
globalce-157	347	1	21	CARDINAL
globalce-157	348	1	zuckerman dm	PERSON
globalce-157	348	2	brown p	ORG
globalce-157	348	3	nissen se	PERSON
globalce-157	349	1	fda	ORG
globalce-157	351	1	2011	DATE
globalce-157	351	2	jun 13;171(11):1006–11.	PERSON
globalce-157	352	1	22	CARDINAL
globalce-157	353	1	dubin jr	PERSON
globalce-157	353	2	simon	PERSON
globalce-157	353	3	norrell k	PERSON
globalce-157	353	4	perera j	PERSON
globalce-157	353	5	gowen j	PERSON
globalce-157	353	6	cil a.	PERSON
globalce-157	353	7	2008-2017	DATE
globalce-157	355	1	2021	CARDINAL
globalce-157	355	2	3;4(5):e217274	CARDINAL
globalce-157	355	3	23	CARDINAL
globalce-157	356	1	fda	ORG
globalce-157	358	1	fda	ORG
globalce-157	358	2	2023	CARDINAL
globalce-157	359	1	2023	CARDINAL
globalce-157	359	2	oct 5	DATE
globalce-157	361	1	24	CARDINAL
globalce-157	362	1	craig	PERSON
globalce-157	362	2	carter p.	PERSON
globalce-157	363	1	2019 oct 1;3(1):56–63. 25	DATE
globalce-157	364	1	levine c	PERSON
globalce-157	364	2	kharod kc	PERSON
globalce-157	364	3	vaughn-cooke m.	PERSON
globalce-157	364	4	fda	ORG
globalce-157	366	1	2020	CARDINAL
globalce-157	367	1	https://recalls-rappels.canada.ca/en https://recalls-rappels.canada.ca/en	PERSON